Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
WALGREEN CO. et al v. WYETH, INC. et al
Case Number:
3:11-cv-06985
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 09, 2012
Teva Says Wyeth Patent Deal Doesn't Step On Antitrust Law
Teva Pharmaceuticals USA Inc. on Friday moved to toss direct purchasers' claims in multiple class actions and individual suits accusing it of conspiring with Wyeth LLC to delay a generic antidepressant's entry into the market, arguing that settling patent litigation with Wyeth didn't violate antitrust law.
-
December 01, 2011
Walgreen, Kroger Join Fray Over Wyeth's Effexor Tactics
Drugstore giants Walgreen Co. and The Kroger Co. on Wednesday became the latest to accuse Pfizer Inc. unit Wyeth LLC of using sham patent litigation and other anti-competitive tactics to block generic competition with its antidepressant Effexor XR.